Market Capitalization (Millions $) |
9 |
Shares
Outstanding (Millions) |
28 |
Employees |
400 |
Revenues (TTM) (Millions $) |
54 |
Net Income (TTM) (Millions $) |
-40 |
Cash Flow (TTM) (Millions $) |
40 |
Capital Exp. (TTM) (Millions $) |
0 |
Centogene N V
Centogene N V is a Netherlands-based company that operates in the genetic testing and diagnostics industry. The company specializes in the diagnostics of rare and genetic diseases as well as the provision of personalized medicine solutions. Centogene was founded in 2006 and has since then developed a unique approach to diagnosing rare diseases through its proprietary CentoMDe database.
The company's platform aims to provide a comprehensive understanding of the genetic basis of rare diseases, and they offer a wide range of diagnostic genetic testing services including targeted gene sequencing, whole-exome sequencing, whole-genome sequencing, and bioinformatics analysis. Their tests are performed using state-of-the-art technology and are designed to provide accurate and reliable results.
Centogene has developed a digitalized platform that connects the company's diagnostic services and proprietary database with the global medical community, providing an innovative ecosystem that enables physicians and researchers to collaborate easily and efficiently. As a result of this approach, Centogene has established partnerships with a wide range of stakeholders, including pharmaceutical and biotech companies, academic institutions, and patient organizations.
The company's mission is to improve the lives of patients by providing accurate diagnoses and personalized medicine solutions that can positively impact their treatment and disease management. To achieve this goal, Centogene N V invests heavily in research and development, collaborating with top academic institutions and pharmaceutical companies to innovate and improve its services.
Overall, Centogene N V is a leader in the genetic diagnostics industry, combining state-of-the-art technology with innovation and collaboration to improve patient care and disease management.
Company Address: Am Strande 7 Rostock 18055
Company Phone Number: 381 80113 500 Stock Exchange / Ticker: NASDAQ CNTG
|